Your session is about to expire
← Back to Search
Dietary Supplement
2021 PMT iAge® Intervention Trial by Edifice Health
N/A
Waitlist Available
Led By David Furman, PhD
Research Sponsored by Edifice Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, day 50, day 120 and day 210
Summary
This trial tests dietary supplements tailored to different immune system types in adults. The goal is to reduce chronic inflammation, which naturally increases with age, to slow down aging and improve health. Participants will be monitored through blood tests and wearable devices.
Eligible Conditions
- Chronic Inflammation
- Inflammaging
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at baseline, day 50, day 120 and day 210
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, day 50, day 120 and day 210
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in inflammatory age (iAge®) scores from Baseline to end of study intervention
Secondary study objectives
Anthropometric and metabolic measurements from Baseline to end of study intervention
Change in cardiovascular health from Baseline to end of study intervention
Change in frailty and mobility from Baseline to end of study intervention
+4 moreOther study objectives
Assessment of skin and scalp health from Baseline to end of study intervention
Changes in metabolomic profile
Changes in the gut microbiome at Baseline to end of study intervention in a subset of participants
+4 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Dietary supplementsActive Control1 Intervention
Dietary supplements are either (1) designated as Generally Recognized As Safe (GRAS) by the Food and Drug Administration or (2) compounds at similar concentrations to those found in foods.
Group II: PlaceboPlacebo Group1 Intervention
Placebo-matched formulations
Find a Location
Who is running the clinical trial?
Edifice HealthLead Sponsor
David Furman, PhDPrincipal InvestigatorChairman of the Scientific Advisory Board